![]() |
|
|
Vol. 19, Issue 12, 5131-5142, December 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Institute of Molecular Biology, University of Oregon, Eugene, OR 97403
Submitted June 20, 2008;
Revised August 20, 2008;
Accepted September 8, 2008
Monitoring Editor: Sandra Lemmon
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The best-characterized member of the V-ATPase family is present in the yeast Saccharomyces cerevisiae (Graham et al., 2003
; Kane, 2006
), because the V-ATPase is essential for cell viability in all eukaryotes except fungi. In yeast, the V-ATPase acidifies the lumen of the vacuole, Golgi, and endosomes by establishing an ATP-driven proton gradient across the membrane. In turn, various membrane-bound ion transporters/proton exchangers use this gradient to sequester metal ions to the vacuole and other cellular organelles. The combined action of the V-ATPase and membrane transporters plays a key role in maintaining cellular homoeostasis in yeast (Kane, 2006
).
The V-ATPase complex can be functionally separated into two subcomplexes: the V1 domain involved directly in ATP hydrolysis and the V0 domain responsible for the translocation of protons across a membrane bilayer. The V-ATPase complex in yeast is composed of 14 integral and peripheral membrane subunits. The V0 domain is assembled in the endoplasmic reticulum (ER) and is composed of subunits a, c, c', c'', d, and e encoded by the yeast genes VPH1 or STV1, VMA3, VMA11, VMA16, VMA6 and VMA9, respectively. The V1 domain contains subunits A, B, C, D, E, F, G, and H encoded by the yeast genes VMA1, VMA2, VMA5, VMA8, VMA4, VMA7, VMA10, and VMA13. Subunits A, B, E, G, and c are present in the V-ATPase at more than one copy per complex (Powell et al., 2000
; Ohira et al., 2006
; Kitagawa et al., 2008
).
In yeast, there are two populations of V-ATPase complexes that are identical except for the subunit a isoform present in each complex (Manolson et al., 1992
, 1994
). The presence of the Vph1p subunit a isoform directs localization of the V-ATPase complex to the membrane of the vacuole, and inclusion of the Stv1p subunit a isoform results in the retention of the V-ATPase complex on Golgi and endosomal membranes (Manolson et al., 1994
). The targeting information determining the cellular localization of the Vph1p and Stv1p containing V-ATPase complexes resides in the N-terminal half of each subunit a isoform (Kawasaki-Nishi et al., 2001
).
Yeast cells lacking a functional V-ATPase display a characteristic set of growth phenotypes, collectively referred to as the Vma– phenotype; they are able to grow on rich medium buffered to pH 5.0 but are unable to grow on more alkaline media buffered to pH 7.5 or in the presence of elevated levels of calcium (Kane, 2006
). V-ATPase–deficient cells are unable to acidify their vacuoles, a phenomenon that can be observed at the cellular level by failure to accumulate the fluorescent dye quinacrine in the lumen of the vacuoles (Weisman et al., 1987
). Failure to assemble the V1 subcomplex due to loss of any one of the V1 subunits does not affect the assembly and targeting of the V0 subcomplex in yeast (Graham et al., 2003
). Cells lacking both Vph1p and Stv1p or any one of the other V0 subunits, fail to assemble a complete V0 subcomplex, and this partially assembled complex does not exit the ER. Yeast cells lacking any of the other V0 subunits (except Stv1p) exhibit reduced cellular levels of Vph1p due to increased turnover of this subunit when it is unable to assemble properly into the V0 subcomplex and exit the ER.
In addition to proteins that comprise the fully functional V-ATPase complex, proteins have been identified and characterized that play a role in the assembly of the V-ATPase. Although the V1 and V0 subcomplexes are capable of assembling independently in cells, there is evidence that V1 subunits associate very early with V0 subunits in the ER (Kane et al., 1999
; Kane, 2006
). One interpretation of these data are that although V1 subunit association is not required for V0 assembly in the ER, the normal pathway for V-ATPase assembly could involve association of certain V1 subunits with components of the V0 subcomplex during its assembly in the ER. Intriguingly, the regulator of the ATPase of vacuolar and endosomal membranes (RAVE) complex (Seol et al., 2001
) is required for the stable association of the V1 domain with the V0 domain during biosynthesis (Smardon et al., 2002
) and for the glucose-regulated reassembly of the V1 and V0 domains at the vacuole membrane after glucose depletion (Smardon et al., 2002
; Smardon and Kane, 2007
).
Assembly of the V0 subcomplex occurs in the ER and requires four distinct ER-localized assembly factors (Forgac, 2007
). The peripheral membrane protein Vma22p, and the integral membrane proteins Vma12p and Vma21p are dedicated to the assembly of the V0 domain in the ER (Hirata et al., 1993
; Hill and Stevens, 1994
; Hill and Stevens, 1995
; Jackson and Stevens, 1997
). In the absence of any one of these proteins, the V0 subunits fail to assemble properly in the ER, and the V0 subcomplex does not exit the ER (Graham et al., 2003
). In addition, Vma21p has been shown to escort the V-ATPase complex out of the ER, separating from the complex in a post-ER organelle and then retrieved back to the ER by cellular machinery recognizing the C-terminal dilysine motif on Vma21p (Malkus et al., 2004
). A fourth V-ATPase assembly factor encoded by the PKR1 gene has been found to play a role in how efficiently the V0 subcomplex assembles in the ER. In the absence of Pkr1p, yeast cells possess a very low level (
5–10%) of properly assembled and fully functional V-ATPase complexes that exit the ER and are found on the membrane of the vacuole (Davis-Kaplan et al., 2006
).
The V-ATPase assembly factors have not yet been as extensively studied as the component proteins of the V-ATPase itself. Factors that function in a subtle manner are difficult to discover because in their absence cells may not exhibit a full Vma– phenotype and are therefore not recognized by conventional phenotypic screening of mutant yeast strains. We chose instead to search for proteins that physically interact with the V0 complex, and then examine these for their effect on assembly. Here, we report the identification and characterization of an ER-localized protein, Voa1p, that functions with Vma21p in assembly of the V-ATPase. Voa1p was identified by mass spectrometry as a component of the partially assembled V0–Vma21p complex in the ER. Voa1p localizes to the ER due to a C-terminal dilysine motif, and it associates with Vma21p when the V0 subcomplex is partially assembled, but not when this complex is fully assembled. Cells lacking Voa1p have slightly reduced V-ATPase activity but do not show a Vma– phenotype. An early V-ATPase assembly function for Voa1p is revealed in yeast cells expressing an ER retrieval-deficient form of the assembly factor Vma21p. In these cells, the loss of Voa1p results in a dramatic growth phenotype due to the lack of properly assembled V-ATPase.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
, and all strains used are listed in Table 1. To make vma6
::Kanr (LGY184), the drug resistance marker Kanr plus 300 base pairs of flanking sequence was amplified from cognate BY4743 strains of the homozygous diploid genome deletion collection (Open Biosystems, Huntsville, AL), propagated in pCR4Blunt-TOPO (Invitrogen), reamplified, transformed into SF838–1D
, and selected on YEPD pH 5.0 plus G418 (Invitrogen). The fragment for VOA1 gene replacement was amplified from the corresponding BY4741 strain of the haploid genome deletion collection and used to make voa1
::Kanr (MRY1) by transforming the wild-type yeast strain SF838-1D
, and voa1
::Kanr VMA21::HA (MRY11) by transforming KHY5. The vma9
::Natr (GFY96) strain used in this study represents a replacement with Natr of VMA9(YCL005W-A) and the overlapping open reading frame (ORF) YCL007C. To prepare this strain, natMX4 was amplified from pAG25 (Goldstein and McCusker, 1999
::Kanr to make ycl005w-A-ycl007c
::Natr (GFY90). This region plus 500 base pairs of flanking sequence was amplified and transformed into SF838–1D
giving vma9
::Natr (GFY96). LGY183 was generated by loop in/loop out procedure by using MscI-digested pRS306 vma21QQ::HA (pLG76). For VOA1 gene disruption with Hygr, a PCR fragment was prepared by amplification of the hphMX4 cassette from pAG32 (Goldstein and McCusker, 1999
, LGY183 and KHY5 to yield voa1::Hygr (MRY14), voa1::Hygr vma21QQ::HA (MRY5) and voa1::Hygr VMA21::HA (MRY9), respectively.
|
Affinity Purification for Mass Spectrometry
vph1
(KHY31) yeast cells expressing Vma21p-HA from plasmid pKH28 and control strain vph1
without plasmid were grown in SD medium, diluted to 0.4 OD600/ml in YEPD pH 5.0, and grown to OD600 = 1. Cells (500 OD) were collected by centrifugation and suspended on ice in phosphate-buffered saline (PBS) (126 mM NaCl, 2.5 mM KCl, and 10 mM Na2HPO4/KH2PO4, pH 7.1) plus protease inhibitors (EDTA-free 1x Complete; Roche Diagnostics, Indianapolis, IN), 2 mM benzamidine, and 1 mM phenylmethylsulfonyl fluoride). Glass bead lysates were obtained using a vortex mixer (Catley, 1988
), debris and unlysed cells were removed by centrifugation (500 x g; 10 min; 4°C), and the pellet was washed once. The combined supernatants were centrifuged (13,000 x g; 20 min; 4°C), and the pellet, constituting the membrane fraction, was washed once. Membranes were solubilized by suspension in 4 ml of P13 buffer (1% C12E9; Sigma-Aldrich, St. Louis, MO) in PBS plus protease inhibitors) and incubated on ice for 1 h with occasional agitation. The solubilized membrane fraction was cleared by centrifugation (16,000 x g; 15 min; 4°C), and the supernatant was transferred to a disposable column containing 40 µl of washed anti-HA agarose (80 µl of 50% slurry, Sigma-Aldrich or Covance Research Products, Berkeley, CA). Proteins were batch adsorbed for 2 h at 4°C with gentle agitation. The affinity resin was washed at 4°C with 4 x 1 ml of P13 buffer and 0.75 ml of Tris-buffered saline (TBS) (150 mM NaCl and 50 mM Tris-HCl, pH 7.5) followed by light centrifugation (1000 x g; 10 s). Columns were moved to room temperature and a two-step elution (60 µl, 10 min followed by 75 µl, 20 min) was used to recover bound proteins. The elution buffer used was either 0.4 mg/ml HA peptide (Sigma-Aldrich), 0.05% C12E9 in TBS, or 8 M urea, 0.05% C12E9 in TBS. Affinity purification from vph1
(KHY31) cells with and without HA-Voa1p expressed from plasmid (pMR072) was done in the same manner, except 140 OD of cells were used, and the protocol was scaled accordingly. The elution buffer used was 0.1 M glycine-HCl, pH 2.8. Affinity extracts were separated on analytical 10–20% SDS-polyacrylamide gel electrophoresis (PAGE) minigels (Bio-Rad, Hercules, CA) and silver stained (SilverQuest; Invitrogen) for inspection, and separated on preparative gels stained with silver or Coomassie (SimplyBlue SafeStain; Invitrogen) for mass spectrometry.
Identification of Proteins by Mass Spectrometry
Sections were excised from SDS-PAGE gels, washed with water, and "in gel" protein digestion with trypsin was carried out using published protocols (Shevchenko et al., 1996
), both with and without reduction/alkylation before the tryptic digest. Peptide samples were concentrated and desalted using microC18 ZipTips (Millipore, Billerica, MA) and dried. Mass spectrometry data were collected and evaluated at the Proteomics Shared Resource (Fred Hutchinson Cancer Research Center, Seattle, WA) and at the University of Oregon Proteomics Facility (Eugene, OR). The samples were resuspended and analyzed by liquid chromatography (LC)/electrospray ionization tandem mass spectrometry (MS/MS), with a two-dimensional nano-high-performance liquid chromatograph (Eksigent, Dublin, CA) coupled to a LTQ-FT (Thermo Scientific, Waltham, MA) mass spectrometer using an instrument configuration as described (Yi et al., 2003
). In-line de-salting (5-µm, 200 Å Magic C18AQ resin, Michrom Bioresources, Auburn, CA) was followed by peptide separations on a 75 µm x 250 mm Picofrit (New Objective, Woburn, MA) reversed-phase column packed with Magic 5-µm 100 Å C18AQ resin (Michrom Bioresources) directly mounted on the electrospray ion source. A 400 nl/min gradient from 2 to 40% acetonitrile in 0.1% formic acid followed by 80% acetonitrile, 0.1% formic acid was used for chromatographic separations. The linear ion trap Fourier transform (FT) instrument was operated in the data-dependent mode, switching automatically between MS survey scans in the FT analyzer and MS/MS spectra acquisition in the linear ion trap. The five most intense ions from the FT full scan were selected for fragmentation. Selected ions were dynamically excluded for 45 s. Collected mass spectrometry data were subjected to the protein database search algorithm X!Tandem (Craig and Beavis, 2004
) configured with the COMET score module plug-in (MacLean et al., 2006
), and identifications were validated using PeptideProphet (Keller et al., 2002
). The protein database used for peptide identification was the translated open reading frame FASTA file from the Saccharomyces Genome Database (www.yeastgenome.org) downloaded 1 November 2006. Peptide identification results were filtered and sorted in Computational Proteomics Analysis System (Rauch et al., 2006
) by using a Peptide Prophet minimum probability cut-off of 0.9 and an ion% cut-off of 0.15.
Protein Extraction from Membranes
A glass-bead lysate was prepared from voa1::Hygr cells expressing HA-Voa1p (pMR072) as described under Affinity Purification. After removal of large particles by centrifugation, the sample was divided into thirds (22 OD equivalents each). Membrane pellets were obtained by centrifugation (13,000 x g; 20 min; 4°C) and washed once. Membrane protein solubilization was done essentially as published previously (Kaiser et al., 2002
). Briefly, the pellets were suspended in 0.2 ml of either PBS or 0.1 M NaCO3, pH 11.5, or 1% Triton X-100 in PBS with protease inhibitors included in all three treatments. The suspensions were incubated on ice for 45 min and then centrifuged (100,000 x g; 30 min; 4°C). The supernatant fractions were removed and saved separately; the pellet fractions were reconstituted in their respective treatment conditions to the same volume as the supernatant fraction. All fractions were adjusted to contain 0.8x sample buffer (1x sample buffer: 8 M urea, 5% SDS, 5% β-meraptoethanol, 0.01% bromphenol blue, 40 mM Tris-HCl, pH 6.8) and resolved by SDS-PAGE. Western blots were prepared using the following primary antibodies: monoclonal anti-Pho8p (1D3; Invitrogen), rabbit anti-Vma6p (Bauerle et al., 1993
), or monoclonal anti-HA (Sigma-Aldrich). Goat anti-mouse or anti-rabbit secondary antibodies conjugated to horseradish peroxidase were used (Jackson ImmunoResearch Laboratories, West Grove, PA) and detected by enhanced chemiluminescence (ECL).
Endoglycosidase H (Endo H) Assay
Solubilized membranes were prepared from voa1
::Kanr cells expressing HA-Voa1p (pMR072) as described under Affinity Purification, except glass bead lysis was in 10 mM Na2HPO4/KH2PO4, pH 7.1, and membranes were solubilized with 1% C12E9 in the same buffer. Both treatments were done in the presence of protease inhibitors. A portion of the cleared, solubilized membrane fraction was withdrawn to serve as untreated control. Of the remainder, 2 OD600 equivalents were denatured in 0.5% SDS, 1% C12E9, 40 mM dithiothreitol, 3.5 mM phosphate buffer, pH 7.1, in a final volume of 40 µl and incubated at 55°C for 15 min. Then, 32 µl of 1.25% C12E9, 125 mM sodium citrate, pH 5.5, 2.5x protease inhibitors were added, mixed, and 36 µl was dispensed into tubes containing 4 µl of Endo Hf (New England Biolabs, Ipswich, MA) or 4 µl of Endo Hf-storage buffer (50 mM NaCl, 2 mM EDTA, and 50 mM Tris-HCl, pH 7.5). The resulting 40-µl reaction and control were incubated at 37°C for 3 h. Samples were adjusted to contain 0.8x sample buffer and analyzed by SDS-PAGE followed by immunoblotting by using monoclonal anti-HA primary antibody (Sigma-Aldrich) and horseradish conjugated anti-mouse secondary antibody (Jackson ImmunoResearch Laboratories). Blots were developed using ECL.
Whole Cell Extract Preparation and Immunoblotting
Yeast cultures were raised in SD medium, diluted to 0.4 OD600/ml in YEPD, pH 5.0, and grown to OD600 = 1. Ten OD600 of cells were harvested, chilled on ice and suspended in 0.1 ml of 1x sample buffer. Ice-cold glass beads (0.1 ml) were added and the suspension vortexed 4x for 1 min with 1-min cooling intervals on ice. Lysates were removed by pipetting and cleared by centrifugation. The supernatants, constituting the whole cell extracts, were resolved by SDS-PAGE, transferred to nitrocellulose membranes, and probed with antibodies. Monoclonal primary antibodies used were anti-HA (Covance Research Products), anti-Vph1p (10D7; Invitrogen), anti-Vma1p (8B1; Invitrogen), and anti-Dpm1p (5C5; Invitrogen), with secondary horseradish-conjugated anti-mouse antibody (Jackson ImmunoResearch Laboratories), followed by ECL detection.
Native Immunoprecipitation
Analysis of c-myc-Voa1p coimmunoprecipitation with Vma21p-HA was done following the Affinity Purification for Mass Spectrometry protocol with the following modifications: 100 OD600 of cells were used, and the protocol was scaled proportionally. A portion of the cleared, solubilized membrane fraction was adjusted to 0.8x sample buffer to serve as measure of protein input, the remainder was adsorbed to 10 µl of anti-HA agarose (Sigma-Aldrich). The resin was washed, and bound proteins were recovered by elution with 2x 30 µl of 1x sample buffer but omitting β-meraptoethanol and bromphenol blue. Input and immunoprecipitates were separated on SDS-PAGE gels and analyzed by Western blotting by using monoclonal anti-Vph1 (10D7) and polyclonal anti-c-myc (Santa Cruz Biotechnology, Santa Cruz, CA) primary antibodies. Equal amounts of Vma21p-HA were present in input fractions well as immunoprecipitate fractions from all strains tested as ascertained by probing blots with anti-HA antibodies.
Fluorescence Microscopy
The acidification of vacuoles in various yeast strains was visualized using the lysosomotropic fluorescent dye quinacrine. Quinacrine staining of live yeast cells was conducted as described previously (Weisman et al., 1987
; Flannery et al., 2004
). Quinacrine was used at a final concentration of 200 µM prepared in 100 mM 2-(N-morpholino)ethanesulfonic acid (MES), pH 7.7, to stain acidified vacuoles, whereas concanavalin A tetramethylrhodamine (Invitrogen) was added at a final concentration of 50 µg/ml to allow for fluorescent visualization of the cell surface.
Localization of green fluorescent protein (GFP)-tagged proteins and stained DNA were determined by fluorescence microscopy. One milliliter of exponentially growing cells was harvested by centrifugation for 30 s and resuspended in 100 mM MES, pH 7.7, 2% glucose, and 5 mg/ml Hoechst 33342 DNA dye. Cells were fixed by the addition of formaldehyde solution (final concentration, 3.7%) and incubated at room temperature for 5 min. Cells were collected by centrifugation and washed twice with buffered glucose before visualization.
Samples for indirect immunofluorescence were prepared as described previously and probed with anti-HA antibody (Covance Research Products; Conibear and Stevens, 2002
). Images were acquired on an Axioplan 2 fluorescence microscope (Carl Zeiss,) using 100x objective and manipulated using AxioVision software (Carl Zeiss, Thornwood, NY).
V-ATPase Activity Assay
Yeast vacuoles were isolated from wild-type (KHY5) and voa1::Hygr (MRY9) strains using the method described by Uchida et al. (1985)
. Freshly prepared vacuoles were assayed for concanamycin A-sensitive ATPase activity by using a coupled spectrophotometric assay as described previously (Conibear and Stevens, 2002
). Vacuole membranes prepared from wild-type and voa1::Hygr cells and were assayed 11 and 12 times, respectively, with the error expressed as SD.
| RESULTS |
|---|
|
|
|---|
strain background was chosen because partially assembled V0–Vma21p complex forms in the ER, but it is unable to exit the ER. HA-epitope–tagged Vma21p (Vma21p-HA) was expressed in vph1
cells and purified from solubilized membranes by affinity chromatography using gentle detergent conditions to preserve protein–protein interactions. Affinity extracts were separated by analytical SDS-PAGE and visualized by silver staining (Figure 1A). In addition to known V0 proteins a prominent band migrated at
35 kDa, just ahead of Vma6p. Gel sections were cut from identical preparative-scale gels and subjected to digestion with trypsin. The peptides were extracted from the gel and analyzed by LC MS/MS. The mass spectrometric results confirmed the presence of V0 subunits but also identified the prominent unknown protein as the uncharacterized ORF YGR106C, which is predicted to encode a 265-amino acid protein (Figure 1B).
|
Mass spectrometric analysis of Voa1p having an HA-tag after Asp25 confirmed cleavage of the signal sequence. HA-Voa1p was expressed in vph1
cells, affinity purified, and resolved by SDS-PAGE. A section containing the appropriate band was cut from the gel, treated with trypsin, and the resulting peptides were recovered. Two signature peptides were detected by LC MS/MS; the first is as expected from the amino acid sequence of the full-length protein, but the second is formed only when Voa1p has Asp25 at its N terminus as a result of signal peptide cleavage (Figure 1C). Consequently, signal sequence cleavage produces a processed protein where the bulk of Voa1p is located on the lumenal side of the ER and the C-terminal transmembrane segment serves as an anchor (Figure 1D). This topology results in the cytosolic exposure of the C-terminal, dilysine ER retention motif, KKNN, and would make available three asparagine residues in the lumenal domain as sites of possible N-linked glycosylation (Figure 1D).
Voa1p Is an Integral Membrane Glycoprotein
To confirm that Voa1p is an integral membrane protein, membrane fractions were prepared from yeast cells expressing HA-Voa1p and treated with either PBS, Na2CO3, pH 11.5, or 1% Triton X-100. Alkali treatment with Na2CO3 extracts peripherally associated membrane proteins from isolated membranes but not integral membrane proteins, which can only be extracted by solubilization with detergent (Fujiki et al., 1982
). The integral membrane protein alkaline phosphatase (Pho8p) and the V-ATPase peripheral membrane protein Vma6p served as controls. As shown in Figure 2A, the integral membrane protein control Pho8p remained in the membrane pellet fraction (P) after treatment with either buffer or Na2CO3. Treatment with the detergent Triton X-100 was required to produce soluble Pho8p that can be extracted into the supernatant fraction (S). The peripheral membrane protein control Vma6p was extracted from the membrane pellet fraction into the supernatant fraction by treatment with either Na2CO3 or detergent. Like Pho8p, Voa1p remained with the membrane pellet fraction when treated with buffer or Na2CO3 and was only extracted from the membranes by treatment with detergent, indicating that Voa1p is an integral membrane protein.
|
36 kDa, as shown in Figure 2A, bottom. This is larger than both the 30.8 kDa predicted for the full-length protein and the 28.1-kDa protein resulting from signal cleavage. Carbohydrate addition to one or more of the three N-glycosylation sites present in Voa1p could contribute to this increase in apparent molecular mass (Figure 1D). To examine this, solubilized membranes prepared from cells expressing HA-Voa1p were denatured with SDS at 56°C for 15 min, followed by incubation with Endo H at 37°C for 3 h, and HA-Voa1p analyzed by Western blotting. The results in Figure 2B show that Voa1p in the sample treated with Endo H migrated as a smaller protein compared with protein in the untreated sample. Denaturation under harsher conditions (65°C, 15 min or 100°C, 5 min) and extending the Endo H digest (37°C, 18 h) gave the same results. The apparent size difference of
2 kDa is consistent with oligosaccharide addition to a single asparagine residue (Kaiser et al., 2002
Voa1p Is Required for V0 Assembly in vma21QQ Cells
Voa1p and Vma21p are encoded by neighboring ORFs on chromosome VII, and the two proteins are encoded on opposite strands, separated by only 156 base pairs of 3'-noncoding sequence (Figure 3A). Western blots of extracts from a voa1
::Kanr strain with an integrated HA-tagged VMA21 allele (VMA21::HA) revealed that Vma21p levels were reduced two- to threefold in the voa1
::Kanr strain relative to wild-type cells (Figure 3B), with Dpm1p (an unrelated ER membrane protein) as a loading control. Furthermore, introducing plasmid-expressed Voa1p into voa1
::Kanr cells did not return Vma21p levels to those found in wild-type cells. Thus, replacing the VOA1 ORF with Kanr interfered with the expression level of Vma21p. A second voa1 null mutant was prepared where the VOA1 coding sequence was disrupted by replacing the first two nucleotides of the start codon with Hygr. This leaves intact 952 nucleotides of VMA21 3'-flanking sequence (Figure 3A), and in this strain Vma21p levels were indistinguishable from wild-type cells (Figure 3B). All subsequent experiments characterizing the loss of Voa1p were carried out using the insertional disruption of VOA1 by Hygr (voa1::Hygr).
|
|
30% of wild-type V-ATPase activity (Hill and Stevens, 1994
cells, which completely lack a functional V-ATPase. These results indicate that loss of Voa1p has an effect on V-ATPase activity, and this effect is more dramatic in the sensitized background of cells expressing an ER retrieval-deficient form of Vma21p.
Because the function of the V-ATPase is to bring about acidification of the vacuole in yeast, we tested for a defect in vacuolar acidification in voa1::Hygr vma21QQ yeast cells. Quinacrine is a fluorescent dye that accumulates in acidic cellular compartments (Uchida et al., 1985
; Conibear and Stevens, 2002
). After quinacrine uptake, wild-type cells exhibited highly fluorescent vacuoles that showed up as bright green disks when visualized by microscopy (Figure 4B). The binding of concanavalin A-tetramethylrhodamine isothiocyanate to the yeast cell wall showed the outline of the yeast cells in red. Yeast cells expressing Vma21pQQ also accumulate quinacrine, demonstrating vacuolar acidification even though these cells have reduced levels of V-ATPase on the vacuolar membrane. Similarly, voa1::Hygr cells accumulate quinacrine in their vacuoles. Cells lacking Voa1p and expressing Vma21pQQ (voa1::Hygr vma21QQ) failed to accumulate quinacrine, similar to cells completely lacking V-ATPase function (vma21
cells). This result indicates that voa1::Hygr vma21QQ yeast cells lack a functional V-ATPase on their vacuolar membranes and are unable to acidify their vacuoles.
Loss of Voa1p Enhances the V-ATPase Assembly Defect of vma21QQ Cells
The demonstrated loss of V-ATPase function in cells lacking Voa1p and expressing Vma21pQQ could be a result of either a nonfunctional V-ATPase on the vacuole or reduced levels of V-ATPase on the vacuole due to an assembly defect. The V0 subunit Vph1p is normally a very stable protein if upon synthesis it is assembled into the V0 subcomplex and transported to the vacuole membrane (Graham et al., 2003
). However, the levels of Vph1p are dramatically reduced in cells that are defective in the assembly of a complete V0 subcomplex, which is the case when individual V0 subunits or assembly factors (Vma21p, Vma12p, Vma22p, or Pkr1p) are absent (Graham et al., 2003
; Compton et al., 2006
; Davis-Kaplan et al., 2006
). To test for defective V0 assembly, cell extracts were prepared and analyzed by Western blotting for the presence of Vph1p, the V1 protein Vma1p, and Dpm1p as a loading control. As expected, we found that cellular levels of Vma1p present at steady-state are similar in all strains tested; wild-type, the single mutants vma21QQ and voa1::Hygr, the double mutant voa1::Hygr vma21QQ, and vma21
(Figure 5). Because the V1 subcomplex can assemble independently of the V0 subcomplex (Doherty and Kane, 1993
; Graham et al., 2003
), V1 protein levels are generally unaffected by any defect in V0. Consistent with near wild-type growth and quinacrine accumulation for the single mutants vma21QQ and voa1::Hygr, Vph1p levels in these strains were similar to that of wild-type cells (Figure 5). Likewise, a Western blot of more dilute extracts from wild-type and voa1::Hygr cells failed to reveal differences in Vph1p levels between these cells types (unpublished data). In contrast, the levels of Vph1p were clearly reduced in voa1::Hygr vma21QQ yeast cells compared with wild-type cells, and they were more similar to Vph1p levels found in vma21
cells, which have no detectable functional V-ATPase on the vacuole.
|
, and voa1::Hygr vma21QQ yeast cells, and we visualized Vph1p localization by using fluorescence microscopy. In wild-type cells Vph1p-GFP was assembled into the V-ATPase and targeted to the membrane of the vacuole as observed by GFP green fluorescent staining coincident with the outline of the vacuole as seen by differential interference contrast (Figure 6, top). The nucleus was visualized using the DNA binding dye Hoechst 33342 and shown as a magenta dot within the cell next to the vacuole as can be seen in wild-type cells expressing Vph1p-GFP. The same localization of Vph1p-GFP on the vacuolar membrane was observed in the single mutants vma21QQ and voa1::Hygr (unpublished data).
|
cells (Figure 6, middle). Vph1p-GFP in voa1::Hygr vma21QQ yeast cells also demonstrated perinuclear and cortical ER staining, rather than vacuolar staining, indicating that Vph1p was unable to exit the ER. The effect of loss of Voa1p seemed specific for the V-ATPase because a plasma membrane (Pma1p) and several vacuolar membrane proteins (Pmc1p, Zrc1p, and Pho8p) all localized normally in cells lacking Voa1p (unpublished data). Together, our results indicate that vma21QQ cells are dependent on Voa1p for V0 subcomplex assembly and that Voa1p functions with Vma21p in V0 assembly.
Voa1p Is a V-ATPase Assembly Factor Localized to the ER with Vma21p
The subcellular localization of Voa1p was determined by indirect immunofluorescence by using the HA epitope-tagged version of the protein (HA-Voa1p). Immunolocalization of HA-Voa1p revealed a perinuclear (the nucleus visualized by 4',6-diamidino-2-phenylindole [DAPI]) and cortical ER membrane staining pattern, indicating that Voa1p localizes to the ER membrane (Figure 7). Voa1p, like Vma21p, possesses a C-terminal dilysine motif that may function in the retention of Voa1p in the ER. To test this, we examined by indirect immunofluorescence the localization of HA-Voa1p and Voa1p in which the dilysines have been changed to diglutamines (HA-Voa1pQQ). As shown in Figure 7, modification of the two amino acids in Voa1p changed the localization pattern from ER to vacuole membrane. These results indicate that Voa1p is an ER localized V-ATPase assembly factor possessing a functional dilysine ER-retrieval motif.
|
|
cells. To better understand how Voa1p participates in the assembly of the V-ATPase, we examined in more detail the interaction of Voa1p with Vma21p. We compared the Voa1p–Vma21p interaction in various mutant backgrounds lacking individual V0 subunits or a V1 subunit. Vma21p-HA was immunoprecipitated under native conditions by using solubilized membrane fractions prepared from wild-type, vma1
, vph1
, vma3
, vma6
, vma9
, vma11
, and vma16
yeast cells expressing both Vma21pHA and c-myc-Voa1p.
Immunoprecipitates obtained from wild-type, vph1
, and vma1
cells were probed for the presence of Voa1p and the V0 subunit Vph1p. As shown in Figure 9A, very little Voa1p was found associated with Vma21p in wild-type cells. At the same time significant amounts of Vph1p copurified with Vma21p from these cells (Figure 9A, top), indicating that V0–Vma21p subcomplexes were present in wild-type cells but that they did not contain Voa1p. A similar result was observed for V0–Vma21p subcomplexes immunoprecipitated from vma1
cells. Cells lacking the V1 protein Vma1p assemble a complete V0–Vma21p subcomplex that exits the ER normally, even though these cells do not form a V1 complex and therefore have no functional V-ATPase (Graham et al., 2003
).
|
cells, we found considerable amounts of Voa1p coprecipitating with Vma21p (Figure 9A), consistent with the affinity purification results shown in Figure 1A. This result indicates that Voa1p preferentially associates with a V0–Vma21p complex lacking Vph1p compared with the fully assembled V0 subcomplex found in wild-type and vma1
cells.
We also examined how the loss of any of the remaining five V0 subunits affects the interaction between Voa1p and Vma21p. In the absence of either the peripheral membrane subunit Vma6p or the integral membrane subunit Vma9p, Voa1p is found associated with the V0–Vma21p complex (Figure 9B). As we have reported previously, vma6
or vma9
strains contain Vma3p, Vma11p, and Vma16p in incomplete V0 subcomplexes associated with Vma21p (Malkus et al., 2004
; Compton et al., 2006
). These incomplete V0 complexes remain in the ER. In addition, a small amount of Voa1p can associate with the incomplete V0–Vma21p complex lacking Vma16p.
Vma3p, Vma11p, and Vma16p are modeled to form a "proteolipid" ring that bridges the interaction between Vma21p and the remaining V0 subunits (Malkus et al., 2004
; Compton et al., 2006
; Wang et al., 2007
). Not surprisingly, very little Voa1p immunoprecipitated with Vma21p in vma3
or vma11
cells. Vma21p and all three of the proteolipid subunits (Vma3p, Vma11p, and Vma16p) are required to form a stable proteolipid ring, and Voa1p preferentially associates with this complex. Together, our results reveal that Voa1p associates with an incompletely assembled V0–Vma21p complex in the ER; specifically, Voa1p binds to V0–Vma21p complexes lacking Vph1p, Vma6p, or Vma9p but containing a partially formed or preferably, a completely formed proteolipid ring.
| DISCUSSION |
|---|
|
|
|---|
Voa1p is an ER-localized integral membrane glycoprotein, which when deleted reduces V-ATPase activity to 75% wild type but results in no apparent Vma– phenotype, i.e., no calcium-sensitive growth and normal acidification of the vacuole. Because it takes at least a three- to fivefold reduction in the level of V-ATPase to observe increased sensitivity to Ca2+ in yeast cells (Liu et al., 1996
; Curtis and Kane, 2002
), the effect on the level of the V-ATPase due to loss of Voa1p is not sufficiently strong to confer a Vma– growth phenotype. This might explain why a clear role for Voa1p in V0 assembly was revealed in cells expressing an ER retrieval-deficient form of Vma21p (Vma21pQQ). vma21QQ yeast cells have reduced V-ATPase levels (Hill and Stevens, 1994
) and a very mild growth defect in the presence of elevated Ca2+ (Figure 4). vma21QQ yeast cells lacking Voa1p (voa1::Hygr vma21QQ) exhibit a severe Ca2+ growth defect and fail to acidify their vacuoles, comparable with cells completely lacking V-ATPase. This is consistent with an absence of functional V-ATPase on the vacuole membrane. V0 domain assembly was severely compromised in voa1::Hygr vma21QQ cells, as evidenced by the decreased cellular levels of the V0 subunit Vph1p and the ER localization of the remaining Vph1p, due to its inability to assemble into a complete V0 domain and exit the ER. In addition, ER localization of Voa1p was found to be critical for its function in V0 domain assembly, because a retrieval-deficient form of Voa1p (Voa1pQQ) could not support V0 assembly in voa1::Hygr vma21QQ cells. The strong enhancement of the Ca2+-sensitive phenotype in vma21QQ cells by deletion of Voa1p supports the model that Voa1p functions together with Vma21p in V0 assembly in the ER.
Characterization of the association of Voa1p with the V0–Vma21p complex revealed that Voa1p is associated with the partially assembled V0–Vma21p complex but did not associate significantly with the fully assembled V0–Vma21p complex found in wild-type cells. Voa1p did not appreciably associate with Vma21p in the absence of the c or c' components of the core proteolipid ring (composed of subunits c, c', and c''; Wang et al., 2007
). This suggests that partial formation of this V0 core is the minimum requirement for Voa1p association with the Vma21p complex, although the presence of all three components of the proteolipid ring led to the highest level of association. This is corroborated by finding Voa1p most strongly associated with the assembling V0–Vma21p complex in cells lacking subunit a (vph1
), subunit d (vma6
), or subunit e (vma9
), wherein the full proteolipid ring is associated with Vma21p. Together, these results indicate that Voa1p associates early with the assembling V0–Vma21p complex in the ER, that it dissociates from the fully assembled V0-Vma21p complex, and that it does not exit the ER in close association with the V0–Vma21p complex. In support of these results, a recent proteomics publication reported proximity between Voa1p (YGR106C) and several V-ATPase subunits by using a split DHFR reporter system (Tarassov et al., 2008
).
V0 Sector Assembly Pathway
With the identification of Voa1p, the assembly of the V0 domain in the ER has been shown to be dependent on at least five proteins: Vma12p, Vma21p, Vma22p, Pkr1p, and now Voa1p. Although a specific role for Pkr1p in V0 assembly has remained elusive (Davis-Kaplan et al., 2006
), the model in Figure 10 outlines specific roles for the four other proteins in the V0 assembly pathway. Vma21p associates with subunits c, c', and c'' to form the core Vma21p–proteolipid ring complex, and loss of neither Vma12p nor Vma22p interferes with the formation of this complex (Malkus et al., 2004
). Voa1p associates stably with this core Vma21p–proteolipid complex (Figure 10, complex 1). A complex of Vma12p and Vma22p interacts with newly synthesized subunit a (Vph1p; Graham et al., 1998
) to form complex 2 in the assembly pathway depicted in Figure 10. The addition of subunits a, d, and e to the core Vma21p–proteolipid complex results in the dissociation of the Vma12–22p complex and Voa1p, and the formation of a stable and fully assembled V0–Vma21p ER-localized complex (Figure 10, complex 3; Malkus et al., 2004
; Compton et al., 2006
; this work). The V0–Vma21p complex is then loaded onto ER-derived coat protein (COP) II vesicles for transport to the cis-Golgi. After dissociation of Vma21p from the V0 domain in the Golgi compartment, COPI-dependent retrieval of Vma21p to the ER (due to Vma21p's C-terminal dilysine motif) allows this assembly/escort factor to function in multiple rounds of V0 assembly and ER-to-Golgi transport of this essential portion of the V-ATPase complex (Malkus et al., 2004
).
|
Genetic and genome-wide screens in yeast have identified the numerous proteins that are required for assembly and regulation of the V-ATPase complex (Kane, 2006
). The identification of the new V0 assembly factor Voa1p by proteomic approaches indicates that there may be many additional factors yet to be discovered to fully understand the coordinated assembly of the V0 domain, the sorting of the V0–Vma21p complex into COPII vesicles for ER-to-Golgi transport, the selective sorting of the Vph1p-containing and Stv1p-containing V-ATPase complexes, and the regulated dissociation/reassembly of the V1V0 complex. voa1 mutants would not have been identified in any of the previous V-ATPase/vacuole acidification screens, because its function was only revealed in a compromised genetic background (vma21QQ). The identification of proteins such as Voa1p that enhance V0 assembly (or proteins that have redundant functions) will require enhancer or suppressor screens in sensitized genetic backgrounds (such as vma21QQ) to identify mutations that act synthetically with mutations that compromise known factors or to identify proteins that when overexpressed alleviate or exacerbate partial V-ATPase deficiencies. Such approaches will reveal new components of the V-ATPase assembly pathway and help elucidate the detailed mechanism of assembly and regulation of the V-ATPase enzyme complex.
| ACKNOWLEDGMENTS |
|---|
yeast strain and the Vph1p-GFP plasmid used in this work. Additionally we want to thank Mark Compton for time and effort creating the artwork used to generate the final model figure. This work was supported by National Institutes of Health grant GM-38006 (to T.H.S.). | Footnotes |
|---|
* These authors contributed equally to this work. ![]()
Address correspondence to: Tom H. Stevens (stevens{at}molbio.uoregon.edu)
Abbreviations used: DAPI, 4',6-diamidino-2-phenylindole; GFP, green fluorescent protein; ER, endoplasmic reticulum; HA, hemagglutinin; V-ATPase, vacuolar-type proton-translocating ATPase; YEPD, yeast extract peptone dextrose.
| REFERENCES |
|---|
|
|
|---|
Bauerle, C., Ho, M. N., Lindorfer, M. A., and Stevens, T. H. (1993). The Saccharomyces cerevisiae VMA6 gene encodes the 36-kDa subunit of the vacuolar H+-ATPase membrane sector. J. Biol. Chem 268, 12749–12757.
Bendtsen, J. D., Nielsen, H., von Heijne, G., and Brunak, S. (2004). Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol 340, 783–795.[CrossRef][Medline]
Beyenbach, K. W., and Wieczorek, H. (2006). The V-type H+ ATPase: molecular structure and function, physiological roles and regulation. J. Exp. Biol 209, 577–589.
Catley, B. J. (1988). Isolation and analysis of cell walls. In: Yeast: A Practical Approach, I. Campell and J. H. Duffus, Oxford, England: IRL Press, 163–183.
Compton, M. A., Graham, L. A., and Stevens, T. H. (2006). Vma9p (subunit e) is an integral membrane V0 subunit of the yeast V-ATPase. J. Biol. Chem 281, 15312–15319.
Conibear, E., and Stevens, T. H. (2002). Studying yeast vacuoles. Methods Enzymol 351, 408–432.[Medline]
Craig, R., and Beavis, R. C. (2004). TANDEM: matching proteins with tandem mass spectra. Bioinformatics 20, 1466–1467.
Curtis, K. K., and Kane, P. M. (2002). Novel vacuolar H+-ATPase complexes resulting from overproduction of Vma5p and Vma13p. J. Biol. Chem 277, 2716–2724.
Davis-Kaplan, S. R., Compton, M. A., Flannery, A. R., Ward, D. M., Kaplan, J., Stevens, T. H., and Graham, L. A. (2006). PKR1 encodes an assembly factor for the yeast V-type ATPase. J. Biol. Chem 281, 32025–32035.
Doherty, R. D., and Kane, P. M. (1993). Partial assembly of the yeast vacuolar H+-ATPase in mutants lacking one subunit of the enzyme. J. Biol. Chem 268, 16845–16851.
Flannery, A. R., Graham, L. A., and Stevens, T. H. (2004). Topological characterization of the c, c', and c'' subunits of the vacuolar ATPase from the yeast Saccharomyces cerevisiae. J. Biol. Chem 279, 39856–39862.
Forgac, M. (2007). Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol 8, 917–929.[CrossRef][Medline]
Fujiki, Y., Hubbard, A. L., Fowler, S., and Lazarow, P. B. (1982). Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J. Cell Biol 93, 97–102.
Goldstein, A. L., and McCusker, J. H. (1999). Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae. Yeast 15, 1541–1553.[CrossRef][Medline]
Graham, L. A., Flannery, A. R., and Stevens, T. H. (2003). Structure and assembly of the yeast V-ATPase. J. Bioenerg. Biomembr 35, 301–312.[CrossRef][Medline]
Graham, L. A., Hill, K. J., and Stevens, T. H. (1998). Assembly of the yeast vacuolar H+-ATPase occurs in the endoplasmic reticulum and requires a Vma12p/Vma22p assembly complex. J. Cell Biol 142, 39–49.
Hill, K. J., and Stevens, T. H. (1994). Vma21p is a yeast membrane protein retained in the endoplasmic reticulum by a di-lysine motif and is required for the assembly of the vacuolar H+-ATPase complex. Mol. Biol. Cell 5, 1039–1050.[Abstract]
Hill, K. J., and Stevens, T. H. (1995). Vma22p is a novel endoplasmic reticulum associated protein required for assembly of the yeast vacuolar H+-ATPase complex. J. Biol. Chem 270, 22329–22336.
Hirata, R., Umemoto, N., Ho, M. N., Ohya, Y., Stevens, T. H., and Anraku, Y. (1993). VMA12 is essential for assembly of the vacuolar H+-ATPase subunits onto the vacuolar membrane in Saccharomyces cerevisiae. J. Biol. Chem 268, 961–967.
Hirata, T., Iwamoto-Kihara, A., Sun-Wada, G. H., Okajima, T., Wada, Y., and Futai, M. (2003). Subunit rotation of vacuolar-type proton pumping ATPase: relative rotation of the G as to c subunit. J. Biol. Chem 278, 23714–23719.
Hirokawa, T., Boon-Chieng, S., and Mitaku, S. (1998). SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 14, 378–379.
Imamura, H., Nakano, M., Noji, H., Muneyuki, E., Ohkuma, S., Yoshida, M., and Yokoyama, K. (2003). Evidence for rotation of V1-ATPase. Proc. Natl. Acad. Sci. USA 100, 2312–2315.
Jackson, D. D., and Stevens, T. H. (1997). VMA12 encodes a yeast endoplasmic reticulum protein required for vacuolar H+-ATPase assembly. J. Biol. Chem 272, 25928–25934.
Kaiser, C. A., Chen, E. J., and Losko, S. (2002). Subcellular fractionation of secretory organelles. Methods Enzymol 351, 325–338.[Medline]
Kane, P. M. (2006). The where, when, and how of organelle acidification by the yeast vacuolar H+-ATPase. Microbiol. Mol. Biol. Rev 70, 177–191.
Kane, P. M., Tarsio, M., and Liu, J. (1999). Early steps in assembly of the yeast vacuolar H+-ATPase. J. Biol. Chem 274, 17275–17283.
Kawasaki-Nishi, S., Bowers, K., Nishi, T., Forgac, M., and Stevens, T. H. (2001). The amino-terminal domain of the vacuolar proton-translocating ATPase a subunit controls targeting and in vivo dissociation, and the carboxyl-terminal domain affects coupling of proton transport and ATP hydrolysis. J. Biol. Chem 276, 47411–47420.
Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002). Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem 74, 5383–5392.[Medline]
Kitagawa, N., Mazon, H., Heck, A. J., and Wilkens, S. (2008). Stoichiometry of the peripheral stalk subunits E and G of yeast V1-ATPase determined by mass spectrometry. J. Biol. Chem 283, 3329–3337.
Liu, J. Z., and Kane, P. M. (1996). Mutational analysis of the catalytic subunit of the yeast vacuolar proton-translocating ATPase. Biochemistry 35, 10938–10948.[CrossRef][Medline]
Liu, Q., Kane, P. M., Newman, P. R., and Forgac, M. (1996). Site-directed mutagenesis of the yeast V-ATPase B subunit (Vma2p). J. Biol. Chem 271, 2018–2022.
MacLean, B., Eng, J. K., Beavis, R. C., and McIntosh, M. (2006). General framework for developing and evaluating database scoring algorithms using the TANDEM search engine. Bioinformatics 22, 2830–2832.
Malkus, P., Graham, L. A., Stevens, T. H., and Schekman, R. (2004). Role of Vma21p in assembly and transport of the yeast vacuolar ATPase. Mol. Biol. Cell 15, 5075–5091.
Manolson, M. F., Proteau, D., Preston, R. A., Stenbit, A., Roberts, B. T., Hoyt, M. A., Preuss, D., Mulholland, J., Botstein, D., and Jones, E. W. (1992). The VPH1 gene encodes a 95-kDa integral membrane polypeptide required for in vivo assembly and activity of the yeast vacuolar H+-ATPase. J. Biol. Chem 267, 14294–14303.
Manolson, M. F., Wu, B., Proteau, D., Taillon, B. E., Roberts, B. T., Hoyt, M. A., and Jones, E. W. (1994). STV1 gene encodes functional homologue of the 95-kDa yeast vacuolar H+-ATPase subunit Vph1p. J. Biol. Chem 269, 14064–14074.
Neubert, C., Graham, L. A., Black-Maier, E. W., Coonrod, E. M., Liu, T. Y., Stierhof, Y. D., Seidel, T., Stevens, T. H., and Schumacher, K. (2008). Arabidopsis has two functional orthologs of the yeast V-ATPase assembly factor Vma21p. Traffic 9, 1618–1628.[CrossRef][Medline]
Ohira, M., Smardon, A. M., Charsky, C. M., Liu, J., Tarsio, M., and Kane, P. M. (2006). The E and G subunits of the yeast V-ATPase interact tightly and are both present at more than one copy per V1 complex. J. Biol. Chem 281, 22752–22760.
Powell, B., Graham, L. A., and Stevens, T. H. (2000). Molecular characterization of the yeast vacuolar H+-ATPase proton pore. J. Biol. Chem 275, 23654–23660.
Rauch, A. et al. (2006). Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. J. Proteome Res 5, 112–121.[CrossRef][Medline]
Rothman, J. H., and Stevens, T. H. (1986). Protein sorting in yeast: mutants defective in vacuole biogenesis mislocalize vacuolar proteins into the late secretory pathway. Cell 47, 1041–1051.[CrossRef][Medline]
Sambrook, J., and Russel, D. W. (2001). Molecular Cloning: A Laboratory Manual, 3rd ed., Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
Seol, J. H., Shevchenko, A., Shevchenko, A., and Deshaies, R. J. (2001). Skp1 forms multiple protein complexes, including RAVE, a regulator of V-ATPase assembly. Nat. Cell Biol 3, 384–391.[CrossRef][Medline]
Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996). Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem 68, 850–858.[Medline]
Sikorski, R. S., and Hieter, P. (1989). A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122, 19–27.
Smardon, A. M., and Kane, P. M. (2007). RAVE is essential for the efficient assembly of the C subunit with the vacuolar H+-ATPase. J. Biol. Chem 282, 26185–26194.
Smardon, A. M., Tarsio, M., and Kane, P. M. (2002). The RAVE complex is essential for stable assembly of the yeast V-ATPase. J. Biol. Chem 277, 13831–13839.
Tarassov, K., Messier, V., Landry, C. R., Radinovic, S., Molina, M. M., Shames, I., Malitskaya, Y., Vogel, J., Bussey, H., and Michnick, S. W. (2008). An in vivo map of the yeast protein interactome. Science 320, 1465–1470.
Uchida, E., Ohsumi, Y., and Anraku, Y. (1985). Purification and properties of H+-translocating, Mg+2-adenosine triphosphatase from vacuolar membranes of Saccharomyces cerevisiae. J. Biol. Chem 260, 1090–1095.
Veses, V., Casanova, M., Murgui, A., Dominguez, A., Gow, N. A., and Martinez, J. P. (2005). ABG1, a novel and essential Candida albicans gene encoding a vacuolar protein involved in cytokinesis and hyphal branching. Eukaryot. Cell 4, 1088–1101.
Wang, Y., Cipriano, D. J., and Forgac, M. (2007). Arrangement of subunits in the proteolipid ring of the V-ATPase. J. Biol. Chem 282, 34058–34065.
Weisman, L. S., Bacallao, R., and Wickner, W. (1987). Multiple methods of visualizing the yeast vacuole permit evaluation of its morphology and inheritance during the cell cycle. J. Cell Biol 105, 1539–1547.
Yi, E. C., Lee, H., Aebersold, R., and Goodlett, D. R. (2003). A microcapillary trap cartridge-microcapillary high-performance liquid chromatography electrospray ionization emitter device capable of peptide tandem mass spectrometry at the attomole level on an ion trap mass spectrometer with automated routine operation. Rapid Commun. Mass Spectrom 17, 2093–2098.[CrossRef][Medline]
Yokoyama, K., Nakano, M., Imamura, H., Yoshida, M., and Tamakoshi, M. (2003). Rotation of the proteolipid ring in the V-ATPase. J. Biol. Chem 278, 24255–24258.
Zheng, L., Baumann, U., and Reymond, J. L. (2004). An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res 32, e115.
This article has been cited by other articles:
![]() |
B. Ediger, S. D. Melman, D. L. Pappas Jr., M. Finch, J. Applen, and K. J. Parra The Tether Connecting Cytosolic (N Terminus) and Membrane (C Terminus) Domains of Yeast V-ATPase Subunit a (Vph1) Is Required for Assembly of V0 Subunit d J. Biol. Chem., July 17, 2009; 284(29): 19522 - 19532. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||